Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Abbott India Ltd. Regulatory Filings 2021

Jun 14, 2021

61121_rns_2021-06-14_f7117be6-99f0-4a3c-87ad-3ca586a7ffcd.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [104 x 103] intentionally omitted <==

Abbott India Limited Registered Office: Tel: (91-22) 5046 1000/2000 Godrej BKC, Plot C-68,”G”Block, 3, Corporate Park, Fax : (91-22) 5016 9400 15-16th Floor, Bandra-Kurla Complex, Sion Trombay Road, E-mail : [email protected] Near MCA Club, Bandra (E), Mumbai - 400 071.India Website : www.abbott.co.in Mumbai - 400 051. India CIN: L24239MH1944PLC007330

BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 001

June 14, 2021

Scrip Code: 500488

Dear Sirs,

Sub: Intimation under Regulation 23 (9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the Accounting Standards for the year ended March 31, 2021.

The above disclosure is also available on the website of the Company i.e. www.abbott.co.in

This is for your information and record.

Kindly acknowledge the receipt of the same.

Thank you.

Yours faithfully,

Abbott India Limited

==> picture [69 x 55] intentionally omitted <==

Krupa Anandpara Company Secretary Membership No.: ACS 16536

Encl: a/a

ABBOTT INDIA LIMITED

DISCLOSURE OF RELATED PARTY TRANSACTIONS FOR THE FINANCIAL YEAR ENDED MARCH 31, 2021

A) Parties where control exists :

Ultimate Holding Company : Abbott Laboratories, USA Holding Company : Abbott Capital India Ltd., UK

B) Other related parties with whom transactions have taken place during the year : I) Fellow subsidiaries : British Colloids Ltd., U.K. Abbott Healthcare Products Ltd., U.K Abbott Healthcare Private Ltd., India Abbott International LLC, USA Abbott Products Operations AG., Switzerland Abbott Laboratories (Singapore) Pte Ltd., Singapore Abbott GmbH, Germany Alere Medical Private Limited, India Abbott Laboratories S.A., Switzerland Abbott Laboratories S.A., Dubai Abbott Laboratories Services LLC, Sri Lanka Branch St Jude Medical India Private Limited, India

II) Key Management personnel and Independent directors:

Mr. Anil Joseph, Managing Director (w.e.f. July 1, 2020)

Mr. Ambati Venu, Non-executive Director (ceased to be the Managing Director effective close of business hours on February 29, 2020) Mr. Munir Shaikh, Chairman

Mr. Rajiv Sonalker, Whole-Time Director

Mr. Krishna Mohan Sahni, Independent Director (ceased to be the Director effective close of business hours on October 28, 2019)

Ms. Anisha Motwani, Independent Director (w.e.f. April 25, 2018) Mr. Sudarshan Jain, Independent Director (w.e.f. April 1, 2019) Ms. Shalini Kamath, Independent Director (w.e.f. October 29, 2019)

C) Transactions during the year :

I) Transactions with the Holding Company during the year

I) Transactions with the Holding Company during the year
(Rupees in Crores)
For the year ended
March 31, 2021
For the year ended
March 31, 2020
Abbott Capital India Ltd., UK
Remittance of dividend
267.98 69.67

II) Transactions with Fellow Subsidiaries during the year

i) Remittance of dividend :

For the year ended
March 31, 2021
For the year ended
March 31,2020
British Colloids Ltd., U.K.
Remittance of dividend
Abbott Healthcare Products Ltd., U.K.
Remittance of dividend
36.75
93.62
9.56
24.34
ii) Sales to fellow subsidiaries :
For the year ended
March 31, 2021
For the year ended
March 31, 2020
Abbott Healthcare Private Ltd., India
Sales of stock-in-trade
Sales of raw materials
Abbott Products Operations AG., Switzerland
Sales of stock-in-trade
Abbott Laboratories Services LLC, Srilanka Branch
Sale of capital goods
60.94
0.74
-
0.02
56.86
47.12
0.86
-
iii) Purchases from fellow subsidiaries :
For the year ended
March 31, 2021
For the year ended
March 31, 2020
Abbott Healthcare Private Ltd., India
Purchase of raw materials
Purchase of stock-in-trade
Abbott Products Operations AG., Switzerland
Purchase of raw materials
Purchase of stock-in-trade
Alere Medical Private Limited, India
Purchase of capital goods
0.07
69.53
316.48
84.12
0.01
4.92
145.06
297.28
80.04
-

ABBOTT INDIA LIMITED

DISCLOSURE OF RELATED PARTY TRANSACTIONS FOR THE FINANCIAL YEAR ENDED MARCH 31, 2021

iv) Other expenses to fellow subsidiaries :
(Rupees in Crores)
iv) Other expenses to fellow subsidiaries :
(Rupees in Crores)
iv) Other expenses to fellow subsidiaries :
(Rupees in Crores)
iv) Other expenses to fellow subsidiaries :
(Rupees in Crores)
iv) Other expenses to fellow subsidiaries :
(Rupees in Crores)
For the year ended
March 31, 2021
For the year ended
March 31, 2020
Abbott Healthcare Private Ltd., India
Shared and support services
Promotional expenses
Conversion charges
Payment of lease liabilities
Finance costs

Electricity and communication expenses
Alere Medical Private Limited, India
Promotional expenses
53.07
0.88
15.64
33.16
10.69
0.92
0.06
10.14
0.63
16.63
32.89
1.98
0.72
0.06
_In the previous year, the Company adopted Ind AS 116 'Leases', with the date of initial application as April 1, 2019._
v) Deposit to fellow subsidiary :*
For the year ended
March 31, 2021
For the year ended
March 31, 2020
Abbott Healthcare Private Ltd., India
Interest free additional security deposit paid
0.16 -
vi) Reimbursements to and from fellow subsidiaries :
Reimbursement to Reimbursement from
For the year ended
March 31, 2021
For the year ended
March 31, 2020
For the year ended
March 31, 2021
For the year ended
March 31, 2020
Abbott Healthcare Private Ltd., India
Market research and other expenses
Abbott International LLC, USA
Employee benefits expense, travel and other expenses
Abbott Laboratories (Singapore) Pte Ltd., Singapore
Employee benefits expense, travel and other expenses
Abbott Products Operations AG., Switzerland
Employee benefits expense, travel and other expenses
Abbott Laboratories S.A., Switzerland
Employee benefits expense, travel and other expenses
Abbott GmbH, Germany
Employee benefits expense, travel and other expenses
Abbott Laboratories Services LLC, Sri Lanka Branch
Employee benefits expense, travel and other expenses
0.03
-
0.11
0.28
0.01
0.40
-
-
-
-
-
-
-
-
0.26
0.15
0.00
-
0.14
0.27
-
1.60
0.00
0.10
0.04
0.10
0.29
0.25
vii) Income from fellow subsidiaries :
For the year ended
March 31, 2021
For the year ended
March 31, 2020
Abbott Healthcare Private Ltd., India
Shared and support services (Refer Note 25 (b))
Rent income (Refer Note 25)
Abbott Products Operations AG., Switzerland
Shared and support services (Refer Note 25 (b))
Abbott Laboratories S.A., Dubai
Shared and support services (Refer Note 25 (b))
Abbott Laboratories (Singapore) Pte Ltd., Singapore
Shared and support services (Refer Note 25 (b))
St Jude Medical India Private Limited, India
Shared and support services (Refer Note 25 (b))
Alere Medical Private Limited, India
Shared and support services (Refer Note 25 (b))
51.72
16.26
1.15
1.15
2.98
3.71
1.18
1.27
1.18
1.27
1.23
0.61
0.18
-
viii) Lease liabilities from fellow subsidiary :
For the year ended
March 31, 2021
For the year ended
March 31, 2020
Abbott Healthcare Private Ltd., India
Recognition of lease liabilities*
-
134.55

*In the previous year, the Company adopted Ind AS 116 'Leases', with the date of initial application as April 1, 2019.

For the year ended
March 31, 2021
For the year ended
March 31, 2020
Mr. Munir Shaikh, Chairman 0.15
-
0.17
0.15
0.15
0.11
0.09
0.14
0.12
0.06
Mr. Krishna Mohan Sahni, Independent Director (ceased to be the Director effective close of business hours on October
28, 2019)
Ms. Anisha Motwani, Independent Director (w.e.f. April 25, 2018)
Mr. Sudarshan Jain, Independent Director (w.e.f. April 1, 2019)
Ms. Shalini Kamath, Independent Director (w.e.f. October 29, 2019)
As at
March 31, 2021
As at
March 31, 2020
Trade payable to fellow subsidiaries (Refer Note 20)
Abbott Products Operations AG., Switzerland
Abbott Healthcare Private Ltd., India
Abbott Laboratories (Singapore) Pte Ltd., Singapore
Abbott International LLC, USA
Lease Liabilities to fellow subsidiary (Refer Note 5)
Abbott Healthcare Private Ltd., India
Other payable to fellow subsidiary (Refer Note 21)
Abbott Healthcare Private Ltd., India
Trade receivables from fellow subsidiaries (Refer Note 10)
Abbott Healthcare Private Ltd., India
Abbott Products Operations AG., Switzerland
Other receivables from fellow subsidiaries (Refer Note 14)
Abbott Products Operations AG., Switzerland
Abbott Healthcare Private Ltd., India
Abbott Laboratories Services LLC, Sri Lanka Branch
Abbott International LLC, USA
Abbott Laboratories S.A., Dubai
Abbott Laboratories (Singapore) Pte Ltd., Singapore
Abbott GmbH, Germany
St Jude Medical India Private Limited, India
Alere Medical Private Limited, India
Loan and deposit to fellow subsidiaries
Abbott Healthcare Private Ltd., India (Refer Note 5 and 6)
91.21
8.93
-
0.08*
86.31
14.69
0.03
-
100.22 101.03
110.71 133.18
110.71 133.18
0.45
0.45
0.45 0.45
9.38
-
24.77
0.26
9.38 25.03
0.53
4.65
-
4.70
0.20
0.20
-
0.23
0.19
0.59
0.66
0.02
5.36
0.20
0.23
0.11
0.67
-
10.70 7.84
14.84 14.77